Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Current Opinion in Lipidology
|
May 27, 2017
Remnant lipoproteins
Anette Varbo, Børge G Nordestgaard
Current Opinion in Lipidology
|
July 1, 2014
Remnant cholesterol and ischemic heart disease
Anette Varbo, Børge G Nordestgaard
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 4, 2017
Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113 554 Individuals
Anette Varbo, Børge G Nordestgaard
Annals of Neurology
|
February 7, 2019
Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Anette Varbo, Børge G Nordestgaard
Lancet (London, England)
|
August 19, 2014
Triglycerides and cardiovascular disease
Børge G Nordestgaard, Anette Varbo
European Heart Journal
|
May 23, 2021
Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction
Anette Varbo, Børge G Nordestgaard
Pharmacology & Therapeutics
|
November 30, 2013
Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
Anette Varbo, Marianne Benn, Børge G Nordestgaard
Clinical Chemistry
|
October 13, 2017
Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study
Anette Varbo, Jacob J Freiberg, Børge G Nordestgaard
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 24, 2020
Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease
Christian M Madsen, Anette Varbo, Børge G Nordestgaard
European Heart Journal
|
November 29, 2017
Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study
Christian M Madsen, Anette Varbo, Børge G Nordestgaard
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Current Opinion in Lipidology
|
May 27, 2017
Remnant lipoproteins
Anette Varbo, Børge G Nordestgaard
Current Opinion in Lipidology
|
July 1, 2014
Remnant cholesterol and ischemic heart disease
Anette Varbo, Børge G Nordestgaard
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 4, 2017
Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113 554 Individuals
Anette Varbo, Børge G Nordestgaard
Annals of Neurology
|
February 7, 2019
Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Anette Varbo, Børge G Nordestgaard
Lancet (London, England)
|
August 19, 2014
Triglycerides and cardiovascular disease
Børge G Nordestgaard, Anette Varbo
European Heart Journal
|
May 23, 2021
Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction
Anette Varbo, Børge G Nordestgaard
Pharmacology & Therapeutics
|
November 30, 2013
Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
Anette Varbo, Marianne Benn, Børge G Nordestgaard
Clinical Chemistry
|
October 13, 2017
Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study
Anette Varbo, Jacob J Freiberg, Børge G Nordestgaard
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 24, 2020
Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease
Christian M Madsen, Anette Varbo, Børge G Nordestgaard
European Heart Journal
|
November 29, 2017
Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study
Christian M Madsen, Anette Varbo, Børge G Nordestgaard
Page
of 6